Elias V Haddad

Title: Innovations by Elias V Haddad in Cardiovascular Medicine

Introduction

Elias V Haddad is a notable inventor based in Nashville, TN (US), recognized for his contributions to cardiovascular medicine. He holds 2 patents that focus on methods for diagnosing and treating myocardial infarction, a critical area in medical research.

Latest Patents

Haddad's latest patents include a method for identifying subjects with increased risk of ST-segment elevation myocardial infarction (STEMI). This method involves obtaining a platelet-containing plasma sample from the subject and determining a Prostaglandin E2 (PGE2) phenotype of the platelets. The identification of a potentiating phenotype indicates an increased risk of developing STEMI compared to an inhibitory phenotype. His second patent addresses the diagnosis, prognosis, and treatment associated with cardiovascular events. This includes methods for determining the presence of specific single nucleotide polymorphisms (SNPs) in a sample, which can guide anti-platelet therapy.

Career Highlights

Elias V Haddad is affiliated with Vanderbilt University, where he continues to advance research in cardiovascular health. His work has significant implications for improving patient outcomes in myocardial infarction and related conditions.

Collaborations

Haddad collaborates with esteemed colleagues such as Olivier Boutaud and Eitan Friedman, contributing to a multidisciplinary approach in his research endeavors.

Conclusion

Elias V Haddad's innovative patents and research at Vanderbilt University highlight his commitment to enhancing cardiovascular medicine. His work is paving the way for improved diagnostic and treatment methods in this vital field.